- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-10-0046808

I-Res India Private Limited
About I-Res India Private Limited
Data last updated:
I-Res India Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 02 November 2022.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U33100MP2022PTC063276.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1.98 Cr. It is led by directors including Alessandro Ribolla and Tribhuvan Nath Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhopal, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.95 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.25 Cr and EBITDA of -₹2.19 Cr.
I-Res India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-10-0046808). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of I-Res India
Contact details
I-Res India Private Limited's registered office is in Bhopal, Madhya Pradesh.
- Registered AddressMaple – 176 Ruchi Lifescapes, Jatkhedi Hoshangabad Road, Bhopal, Madhya Pradesh, India – 462026
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of I-Res India Private Limited
FY 2025 filings availableI-Res India Private Limited reported revenue of ₹1.95 Lakh (up 764% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 764% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.19 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2.25 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of I-Res India Private Limited, buy the company report.
Board of directors of I-Res India Private Limited
I-Res India has 6 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alessandro Ribolla | Director | 02 Nov 2022 | 3 Years 11 Months | Current |
| Tribhuvan Nath Singh Also directs: Ap Millennium Private Limited | Director | 13 Nov 2024 | 1 Years 11 Months | Current |
| Pradeep Kumar Saxena Also directs: Ap Millennium Private Limited | Director | 02 Nov 2022 | 3 Years 11 Months | Current |
| Mukesh Hajela | Additional Director | 28 May 2025 | 1 Years 4 Months | Current |
| Parul Shrivastava Also directs: Ap Millennium Private Limited | Additional Director | 10 Jan 2025 | 1 Years 9 Months | Current |
| Kapil H Ilager | Director | 20 Dec 2022 | 3 Years 10 Months | Current |
Peer comparison
I-Res India Private Limited is compared with the 10 companies closest to it by revenue in the Ecommerce and Internet industry (Healthcare Products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Metafora Health Services Private Limited | ₹2.29 Lakh (FY 2024) | -90.0% | Panipat, Haryana, India | |||
| Arechar Nutra Private Limited | ₹2.28 Lakh (FY 2025) | 26.0% | New Delhi, Delhi, India | |||
| Medicrocket Healthcare Private Limited | ₹2.04 Lakh (FY 2022) | Delhi, India | ||||
| True Fortitude Private Limited | ₹2.03 Lakh (FY 2024) | Kanpur, Uttar Pradesh, India | ||||
| Signel Biomedical Private Limited | ₹1.97 Lakh (FY 2022) | Hyderabad, Telangana, India | ||||
| I-Res India Private Limitedthis company | ₹1.95 Lakh (FY 2025) | -₹2.25 Cr | 764.0% | Bhopal, Madhya Pradesh, India | ||
| Medchain Innovation Private Limited | ₹1.83 Lakh (FY 2024) | 486.0% | Delhi, India | |||
| Callhealth Online Services Private Limited | ₹1.69 Lakh (FY 2025) | -19.0% | Hyderabad, Telangana, India | |||
| Bravit Pharmaceuticals Private Limited | ₹1.64 Lakh (FY 2025) | 69.0% | Vadodara, Gujarat, India | |||
| Orymile Traders and Consults Private Limited | ₹1.51 Lakh (FY 2022) | -84.0% | Sangamner, Maharashtra, India | |||
| Indimedo Private Limited | ₹1.5 Lakh (FY 2025) | -86.0% | New Delhi, Delhi, India |
To see the full peer comparison of I-Res India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving I-Res India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for I-Res India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for I-Res India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
I-Res India Private Limited has 10 board changes on record since 2022: 7 appointments and 3 cessations. The latest: Attendra Bartariya ceased to be Director on 22 Aug 2025.
1 earlier event is in the company report.
Frequently asked questions
I-Res India is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 02 November 2022 (4+ years old) and is registered under CIN U33100MP2022PTC063276.
I-Res India has 6 current directors:
- Alessandro Ribolla - Director
- Tribhuvan Nath Singh - Director
- Pradeep Kumar Saxena - Director
- Mukesh Hajela - Additional Director
- Parul Shrivastava - Additional Director
- Kapil H Ilager - Director
The latest financial statements of I-Res India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of I-Res India is U33100MP2022PTC063276. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
I-Res India was incorporated on 02 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of I-Res India by revenue are Metafora Health Services Private Limited, Arechar Nutra Private Limited, Medicrocket Healthcare Private Limited, True Fortitude Private Limited, Signel Biomedical Private Limited and 5 more, all in the Ecommerce and Internet industry (Healthcare Products).
Attendra Bartariya ceased to be Director on 22 Aug 2025. Ramesh Kumar Chowdhary ceased to be Director on 26 Jun 2025. Vivek Sureshchandra Saxena ceased to be Director on 26 Jun 2025. I-Res India has 10 board changes on record in total.
Yes, I-Res India is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-10-0046808).
The registered office of I-Res India is at Maple – 176 Ruchi Lifescapes, Jatkhedi Hoshangabad Road, Bhopal, Madhya Pradesh, India – 462026.
I-Res India operates in the healthcare industry, in the medical and laboratory equipment segment.
The compliance status of I-Res India is compliant as of 25 September 2026. The company is actively filing with the Registrar of Companies.